Name | 4-(4-Methyl-1-piperazinyl)-6-phenyl-2-pyrimidinamine |
---|---|
Synonyms |
2-Pyrimidinamine, 4-(4-methyl-1-piperazinyl)-6-phenyl-
4-(4-Methyl-1-piperazinyl)-6-phenyl-2-pyrimidinamine VUF10460 |
Description | VUF10460 is a non-imidazole histamine H4 receptor agonist; binds to rat H4 receptor with a pKi of 7.46. |
---|---|
Related Catalog | |
Target |
pKi: 7.46 (H4)[1] |
In Vitro | UF10460 binds to rat H3 and H4 receptor with pKi values of 5.75, and 7.46, respectively. VUF10460 displays approximately a 50-fold selectivity for the rat H4 receptor over the H3 receptor[1]. |
In Vivo | HCl-induced rat gastric lesions is significantly enhanced by the H4 receptor agonists VUF10460. This effect is not modified by H4 receptor antagonist JNJ7777120[1]. |
Animal Admin | Rats: VUF10460 is dissolved in 100% DMSO. Gastric lesions are induced in 24 h fasted rats by a single intragastric administration of 0.6 N HCl (5mL/kg volume). Drugs under study are administered subcutaneously 30 min before HCl. Rats are randomly divided to receive single doses (10 and/or 30 mg/kg) of immethridine, methimepip, immepip, VUF8430, VUF10460 or the vehicle, in a 1 mL/kg volume[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 523.8±60.0 °C at 760 mmHg |
Molecular Formula | C15H19N5 |
Molecular Weight | 269.345 |
Flash Point | 270.6±32.9 °C |
Exact Mass | 269.164032 |
LogP | 1.27 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.621 |
Storage condition | 2-8℃ |